Combination of LC-Q-TOF-MS/MS, network pharmacology, and nanoemulsion approaches identifies active compounds of two Artemisia species responsible for tackling early diabetes-related metabolic complications in the liver.
- Moulahoum H et al (2022).
- Phytochem Anal.
- DOI:
- 10.1002/pca.3159
- PubMed:
- 35795911